Ethics Committees, Research

• 

  Subject Areas on Research

  • Accidental communities: race, emergency medicine, and the problem of polyheme. 
  • Adolescent mental health research in Tanzania: a study protocol for a priority setting exercise and the development of an interinstitutional capacity strengthening programme. 
  • Aligning the goals of community-engaged research: why and how academic health centers can successfully engage with communities to improve health. 
  • Approaches to facilitate institutional review board approval of multicenter research studies. 
  • Barriers to Change in the Informed Consent Process: A Systematic Literature Review. 
  • Can underpowered clinical trials be justified? 
  • Cell-based interventions for neurologic conditions: ethical challenges for early human trials. 
  • Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. 
  • Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report. 
  • Community hospital oversight of clinical investigators' financial relationships. 
  • Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. 
  • Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories. 
  • Conducting empirical research on informed consent: challenges and questions 
  • Confidentiality: more than a linkage file and a locked drawer. 
  • Developing model language for disclosing financial interests to potential clinical research participants. 
  • Development of a Health Professions Education Research-Specific Institutional Review Board Template. 
  • Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. 
  • Disclosure of financial relationships to participants in clinical research. 
  • Does informed consent to research require comprehension? 
  • Economic analysis of a single institutional review board data exchange standard in multisite clinical studies. 
  • Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight. 
  • Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: from experimental design to institutional review board approval. 
  • Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems. 
  • Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials. 
  • Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. 
  • Food and Drug Administration and Institutional Review Board Approval of a Novel Prehospital Informed Consent Process for Emergency Research. 
  • Health Professions Education Research and the Institutional Review Board. 
  • Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey. 
  • IRB chairs' perspectives on genotype-driven research recruitment. 
  • Impact of Cognitive Impairment Across Specialties: Summary of a Report From the U13 Conference Series. 
  • Impediments to clinical research in the United States. 
  • Informed consent and investigational new drug abuses in the U.S. military. 
  • Informed consent in human research: what to say and how to say it. 
  • Institutional review board training for community practices: advice from the Agency for Health Care Research and Quality Practice-Based Research Network listserv. 
  • Institutional review boards' use and understanding of certificates of confidentiality. 
  • Maximizing value and minimizing barriers: Patient-centered community consultation for research in emergency settings. 
  • Misplaced flexibility: revise policies but cling to principles. 
  • Obtaining waivers of parental consent: A strategy endorsed by gay, bisexual, and queer adolescent males for health prevention research. 
  • Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board. 
  • Opportunities Missed and Created by the New Common Rule. 
  • Oversight mechanisms for clinical research. 
  • Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings. 
  • Perspective: The case for research justice: inclusion of patients with limited English proficiency in clinical research. 
  • Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. 
  • Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. 
  • Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research. 
  • Quality improvement and evidence-based practice change projects and the institutional review board: is approval necessary? 
  • Randomized clinical trials--removing unnecessary obstacles. 
  • Regulatory and ethical considerations for linking clinical and administrative databases. 
  • Research in nursing education and the institutional review board/ethics committee. 
  • Response to Letter to the Editor from Schutte, Fokkens, Bertens, and Scherpbier re: Research in Nursing Education and the Institutional Review Board/Ethics Committee. 
  • Retooling institutional support infrastructure for clinical research. 
  • Simplifying informed consent for biorepositories: stakeholder perspectives. 
  • Site Variability in Regulatory Oversight for an International Study of Pediatric Sepsis. 
  • Stakeholder Experiences with the Single IRB Review Process and Recommendations for Food and Drug Administration Guidance. 
  • Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial. 
  • The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. 
  • The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. 
  • The Society for Clinical Trials supports United States legislation mandating trials registration. Position paper. 
  • The consent process and children 
  • The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. 
  • Toward protecting the safety of participants in clinical trials. 
  • Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance. 
  • Use of altered informed consent in pragmatic clinical research. 
  • Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature. 
  • Using central IRBs for multicenter clinical trials in the United States. 
  • Variability in IRBs regarding parental acceptance of passive consent. 
  • Who should go first in trials with scarce agents? The views of potential participants. 
• 

  Keywords of People

  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine